Skip to main content
. 2020 Sep 29;14:579958. doi: 10.3389/fnins.2020.579958

TABLE 1.

Characteristics of the study groups.

Controls (n = 61) Febrile seizures (n = 78) Epileptic seizures (n = 16)
Males/females 33/28 43/35 10/6
Age, months 29.4 ± 17.8 (6–72) 24.8 ± 14.5 (6–63) 53.9 ± 45.8 (9–163)*
Body weight, kg 12.9 ± 4.2 (6.8–27) 12.1 ± 3.5 (6.0–23.0) 18.4 ± 13.0 (4.4–56)
History of seizures NA 16 (20.5) 9 (56.3)
Temperature at home, °C 39.6 ± 0.7 (37.7–41.3) 39.3 ± 0.6 (38.0–41.0) NA
Temperature at ED, °C 38.3 ± 1.0 (36.0–40.5) 38.6 ± 0.8 (36.5–40.1) NA
Duration of event, min NA 6.5 ± 8.1 (1–40) 5.1 ± 5.2 (1–20)
Time to presentation, min NA 107 ± 70.7 (1–330) 96.2 ± 60.9 (7–240)§
Laboratory data at ED
Hct, % 35.6 ± 3.7 (27.3–43.3) 37.2 ± 4.2 (28.9–56.0) 38.2 ± 3.3§§(31.8–42.3)§
WBC × 1000/mm3 12.4 ± 7.2 (1.9–40.8) 12.9 ± 7.1 (3.4–34.2) 8.6 ± 2.7 (5.2–14.7)
Na, mmol/L 136.1 ± 3.2 (129–142) 135 ± 2.9 (118–141) 138 ± 2.1 (135–143)
Cl, mmol/L 105 ± 3.2 (98–112) 105 ± 2.6 (98–112) 106 ± 2.2 (101–110)
pH 7.37 ± 0.05 (7.20–7.40) 7.36 ± 0.06 (7.20–7.50) 7.27 ± 0.07** (7.10–7.30)**
CO2, mmHg 31.6 ± 4.4 (21–41) 33 ± 5.1 (24–54) 43.2 ± 10.7 (34–70)
Bicarbonate, mmol/L 21.7 ± 2.6 (13.9–26.1) 21.6 ± 1.6 (17.5–25.3) 21.5 ± 2.6 (14.9–25.2)
Lactate, mmol/L 1.5 ± 0.8 (0.9–4.5) 1.5 ± 0.7 (0.7–4.5) 1.2 ± 0.5 (0.6–2.2)
CRP, mg/dl 50.5 ± 50.2 (0.3–220) 12.6 ± 18.6 (0.3–91) 1.3 ± 2.4 (0.3–8.0)

Data are presented as mean ± SD (range) unless stated otherwise. p = 0.042 vs controls and p = 0.002 vs febrile seizures. p = 0.043 vs. febrile seizures. p = 0.010 vs febrile seizures. §p = 0.755 vs febrile seizures. §§p = 0.039 vs controls. p = 0.002 vs febrile seizures. ∗∗p < 0.001 vs febrile seizures and controls. †⁣†p < 0.001 vs febrile and epileptic seizures. Between-group comparisons were performed with Mann–Whitney U-test, Kruskal–Wallis one-way ANOVA test (with Bonferroni correction for multiple comparisons), χ2 test, or Fisher’s exact test, as appropriate. ED, emergency department; NA, not available; WBC, white blood cell.